Esteller, M. and J. G. J. O. Herman (2004). "Generating mutations but providing chemosensitivity: the role of O 6-methylguanine DNA methyltransferase in human cancer." 23(1): 1.
Fu, D., et al. (2012). "Balancing repair and tolerance of DNA damage caused by alkylating agents." 12(2): 104.
Koranyi, G. (2010). The cut and paste technique fibrin tissue adhesive in pterygium surgery, Institutionen för klinisk neurovetenskap/Department of Clinical Neuroscience.
Liu, T., et al. (2013). "Progress in the pathogenesis of pterygium." 38(12): 1191-1197.
Liu, Y., et al. (2017). "mTORC1 regulates apoptosis and cell proliferation in pterygium via targeting autophagy and FGFR3." 7(1): 7339.
Ozturk, B., et al. (2017). "K-ras oncogene mutation in pterygium." 31(3): 491.
Tradjutrisno, N. J. U. M. (2016). "Pterygium: degeneration, exuberant wound healing or benign neoplasm?" 28(3): 179-187.
Wick, W., et al. (2014). "MGMT testing—the challenges for biomarker-based glioma treatment." 10(7): 372.
Wickström, M., et al. (2015). "Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance." 6: 8904.
Xu, K., et al. (2013). "Increased importin 13 activity is associated with the pathogenesis of pterygium." 19: 604.
Liu J.et al.(2017). “Identification of pterygium-related mRNA expression profiling by microarray analysis.” 31(12):1733.